Page last updated: 2024-10-19

oxaloacetic acid and Amyotrophic Lateral Sclerosis

oxaloacetic acid has been researched along with Amyotrophic Lateral Sclerosis in 2 studies

Oxaloacetic Acid: A dicarboxylic acid ketone that is an important metabolic intermediate of the CITRIC ACID CYCLE. It can be converted to ASPARTIC ACID by ASPARTATE TRANSAMINASE.
oxaloacetic acid : An oxodicarboxylic acid that is succinic acid bearing a single oxo group.

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Tungtur, SK1
Wilkins, HM1
Rogers, RS1
Badawi, Y1
Sage, JM1
Agbas, A1
Jawdat, O1
Barohn, RJ1
Swerdlow, RH1
Nishimune, H1
Ruban, A1
Malina, KC1
Cooper, I1
Graubardt, N1
Babakin, L1
Jona, G1
Teichberg, VI1

Other Studies

2 other studies available for oxaloacetic acid and Amyotrophic Lateral Sclerosis

ArticleYear
Oxaloacetate treatment preserves motor function in SOD1
    Scientific reports, 2021, 05-26, Volume: 11, Issue:1

    Topics: Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Inflammation; Longevity; Mice; Motor

2021
Combined Treatment of an Amyotrophic Lateral Sclerosis Rat Model with Recombinant GOT1 and Oxaloacetic Acid: A Novel Neuroprotective Treatment.
    Neuro-degenerative diseases, 2015, Volume: 15, Issue:4

    Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartate Aminotransferases; Disease Models, Animal; Drug Th

2015